ISMMS, Boehringer Ingelheim to test nintedanib for treating pulmonary fibrosis post-COVID-19… EP News Bureau Nov 20, 2020 The primary endpoint of the study is percent change in forced vital capacity, a measurement of lung function, compared to baseline…
Glenmark launches NINDANIB (nintedanib) for pulmonary fibrosis in India EP News Bureau Oct 14, 2020 Two clinical trials are being rolled out to study the efficacy and safety of Nintedanib as a treatment of SARS-COV2 induced…
